CD44 and myocardial infarction: Although the cardioprotective benefit of CD44 has been identified in alleviating adverse remodeling of the infarcted heart (Huebener et al. 2008), the regulatory role of CD44 in angiogenesis post-MI remains to be emphasized (Chen et al. 2020; Wei et al. 2014).